Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Osiris Sells Osteocel: Up To $137M For Pipeline

Related Content

Osiris Stem Cell Knee Therapy Misses Endpoint

Feb 13 2007

Amgen Will Launch Palifermin In Late January Under Brand Name Kepivance

Dec 15 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window